Opportunities of robotic surgery in treatment of prostate cancer and renal masses in patients with severe comorbidities

Earlier diagnosis of cancer, increased effectiveness of therapeutic measures in combination with improved surgical treatment methods have led to improved prognosis and functional outcomes for patients, increased life expectancy and constant expansion of survival boundaries, as well as an increase in the proportion of patients with comorbidities. With the increase in life expectancy and population aging in general, the problem of comorbidity and "frailty" and the treatment of oncourological diseases in this group of patients are currently receiving increasing attention. Over the past decades, approaches to the management of such patients have changed significantly in favor of expanding the indications for radical treatment. At the same time, robot-assisted surgery, as one of the most modern, effective and safe methods, seems to be an extremely promising way to treat prostate cancer and kidney tumors in patients with severe comorbidities. This article presents world data on the treatment of prostate cancer and kidney cancer in comorbid patients using robotic surgery, as well as our own results of these methods.